KNOXVILLE, Tenn.--(BUSINESS WIRE)--Provectus Pharmaceuticals, Inc. (OTC: PVCT), a development-stage oncology and dermatology biopharmaceutical company, announced today that it will be presenting at the Cancer Immunotherapy: A Long-Awaited Reality conference taking place on October 21, 2010, at the New York Academy of Medicine in New York City.
